Bone Health Technologies introduces the OsteoBoost Vibration Belt, designed to help treat osteopenia and prevent osteoarthritis. It has been granted “Breakthrough Device” designation by the US Food & Drug Administration.

OsteoBoost uses proprietary vibration technology designed to deliver gentle mechanical stimulation to the hips and spine at a precise, individually calibrated frequency, encouraging the body to reduce bone resorption and potentially create new bone. This localized vibration therapy’s effect is to stop the progression of bone loss and prevent the onset of osteoporosis.

An initial study suggests that one 30-minute treatment with OsteoBoost helps reduce bone loss activity in all study participants, providing an average decrease of 14%, a reduction on par with bisphosphonate drugs.

The initial study results were so promising that the National Institutes of Health funded a $2 million study to determine if the positive effects of OsteoBoost could be demonstrated in a longer study with a broader population. This larger, pivotal study is currently enrolling patients and is scheduled to be completed in early 2022, according to a media release from Bone Health Technologies. 

“For years, I have wanted a better option for my patients with low bone density that doesn’t have the potential side effects and the inconvenience of current drug treatments. With OsteoBoost we’ve created a safe, drug-free alternative that is easy and convenient. Now my patients with osteopenia have a new way to improve their bone health and reduce their risk of fracture.”

— Shane Mangrum, MD 

OsteoBoost is derived from NASA technology, which suggests that mechanical stimulation of bones through vibration would improve bone health in astronauts, per the release.

Founded in 2018 by Shane Mangrum, MD, Dan Burnett, MD, and Michael Jaasma, PhD, Bone Health Technologies is focused on improving the lives of millions of people who are currently at risk of developing osteoporosis and subsequent bone fractures.

[Source: Bone Health Technologies]

Related Content:
Injections for Osteoarthritis? More Research is Needed
Total Joint Replacement and the Impact on Future Falls in Osteoarthritis Patients
Mass Spectrometry Aids Search for Osteoarthritis Biomarker